Fairvalue-Calculator Fairvalue-Calculator
EN DE

Biosynex SA (ALBIO) Fair Value & Analysis

Healthcare · FR · Market cap €19.4M

Price€0.8900
Fair Value€0.9339
Upside+4.9%
Quality95/100
Evidence: Low Range €0.6804 – €1.19

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Biosynex SA (ALBIO) currently trades at €0.8900, while our model-based Fair Value estimate is €0.9339 — implying the stock looks roughly 4.9% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immunoblot, molecular biology, and POC for screening, diagnosis, and prevention. It also provides thermometers, tensiometers, oximetry, hearing protection products, oral and dental hygiene products, self-tests, thermal pads, inhalation chambers, and thermotherapy products, as well as anti-mosquito bracelets and waterproof, moisturizing, and sensitive skin spray. The company was incorporated in 2005 and is based in Illkirch-Graffenstaden, France.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -95% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -27% Boston Scientific Corporation (B1SX34) -11% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Biosynex SA (ALBIO) undervalued?
As of Jun 25, 2026, our model estimates a fair value of €0.9339 versus a price of €0.8900 — about +5% (undervalued). Model-based estimate, not financial advice.
What is the fair value of ALBIO?
Our 21-model fair value for Biosynex SA is €0.9339 (as of Jun 25, 2026), built from audited fundamentals. The current price is €0.8900.
What is the quality score of ALBIO?
Biosynex SA has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.